A South Korean research team has identified four promising biomarkers for ankylosing spondylitis (AS) using serum-derived extracellular vesicles (EVs), potentially paving the way for earlier and less invasive diagnosis of this debilitating spinal disease.
In the world of spinal disease diagnostics, a South Korean research team may have just found gold—microscopic, nanosized gold floating in your bloodstream. Their secret weapon? Extracellular vesicles (EVs), the molecular mail carriers that have become darlings of cancer and autoimmune research.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
